Assay methods for the determination of FKBPL expression level in the context of breast cancer
US9110063B2 · kind B2 · utility
0Cited by
0References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 19, 2010 |
| Grant date | Aug 18, 2015 |
| Priority date | — |
| Expiry date | May 30, 2030 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/99
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Disclosed are methods that employ FKBPL as a marker for a subject's sensitivity to endocrine therapies in the treatment of cancers, and as a predictive marker of cancer progression and disease free survival in relation to hormone responsive cancers.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.